Donald K. Scott

Dr. Donald K. Scott is a Professor in the Department of Medicine, specifically within the Endocrinology, Diabetes and Bone Disease division at the Icahn School of Medicine at Mount Sinai in New York City. His research focuses on critical aspects of diabetes pathophysiology and potential therapeutic approaches.

Dr. Scott earned his academic foundation with AB and MA degrees from the University of Missouri, followed by a PhD from Saint Louis University. This educational background has supported his distinguished career in diabetes research.

His research program centers on beta cell biology, investigating molecular mechanisms that protect pancreatic beta cells from damage in diabetes. Dr. Scott's work spans from basic molecular studies to translational research with therapeutic implications, particularly focusing on beta cell protection from glucolipotoxicity, adaptation during pregnancy, and potential regenerative approaches using cellular reprogramming.

With 94 publications to his name, Dr. Scott's scholarly output demonstrates consistent contribution to the diabetes research field. His recent work published in high-impact journals like Nature Communications, Redox Biology, and Cell Reports Medicine reveals an active research program addressing fundamental questions in beta cell biology and diabetes pathogenesis.

• Molecular mechanisms of beta cell protection
• Adaptation of beta cells during metabolic stress
• Pancreatic islet regeneration approaches
• Gestational diabetes mechanisms

Dr. Scott maintains an active laboratory in the Atran Berg Laboratory Building where his team investigates novel therapeutic approaches for diabetes treatment. His office is located at Floor 5, Room 11, 1428 Madison Avenue, New York, NY 10029, serving as the hub for his research and academic activities.